Kelly Fulk, Emily Dalton, Amal Yussuf, Holly Laduca, Jill Dolinsky, Rachel McFarland
Multigene panels (MGP) testing genes associated with multiple cancer syndromes became commercially available in March 2012, presenting healthcare providers with a new way to order genetic testing for hereditary cancer susceptibility.